LUPIN
Back to Cashflow Statement
|
LUPIN Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹1,732 Cr | ₹-2,184 Cr | ₹-337 Cr | ₹-1,572 Cr | ₹-1,885 Cr |
What is the latest Cash Flow from Financing Activities ratio of LUPIN ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹1,732 Cr |
Mar2024 | ₹-2,184 Cr |
Mar2023 | ₹-337 Cr |
Mar2022 | ₹-1,572 Cr |
Mar2021 | ₹-1,885 Cr |
How is Cash Flow from Financing Activities of LUPIN Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹1,732 Cr | Positive | |
Mar2024 | ₹-2,184 Cr | Negative | |
Mar2023 | ₹-337 Cr | Negative | |
Mar2022 | ₹-1,572 Cr | Negative | |
Mar2021 | ₹-1,885 Cr | - |
Compare Cash Flow from Financing Activities of peers of LUPIN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LUPIN | ₹90,003.3 Cr | 2.4% | -0.9% | -14.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,329.0 Cr | 0.9% | 3.7% | -13.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,991.0 Cr | 7.4% | 9% | 8.2% | Stock Analytics | |
CIPLA | ₹126,326.0 Cr | 3.3% | 0.2% | -7.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,126.0 Cr | -0.7% | -1.7% | -0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,324.0 Cr | 1% | -3.2% | -5.2% | Stock Analytics |
LUPIN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LUPIN | 2.4% |
-0.9% |
-14.2% |
SENSEX | 0.7% |
1.1% |
0.9% |
You may also like the below Video Courses